UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data

Brain, behavior, and immunity, 2014-10, Vol.41, p.101-108

2014

Volltextzugriff (PDF)

Cigarette smoke decreases MARCO expression in macrophages: Implication in Mycoplasma pneumoniae infection

Respiratory medicine, 2008-11, Vol.102 (11), p.1604-1610

2008

Volltextzugriff (PDF)

The emerging phenotype of late-onset Pompe disease: A systematic literature review

Molecular genetics and metabolism, 2017-03, Vol.120 (3), p.163-172

2017

Volltextzugriff (PDF)

Risk of respiratory, gastrointestinal, and constitutional health symptoms: A cross-sectional study of Texas adolescent and young adult nicotine and marijuana vapers

Preventive medicine, 2022-06, Vol.159, p.107057-107057, Article 107057

2022

Volltextzugriff (PDF)

Longitudinal trajectories of E-cigarette use among adolescents: A 5-year, multiple cohort study of vaping with and without marijuana

Preventive medicine, 2021-09, Vol.150, p.106670-106670, Article 106670

2021

Volltextzugriff (PDF)

Predictors of JUUL, other electronic nicotine delivery systems, and combustible tobacco initiation among Texas youth

Preventive medicine, 2020-09, Vol.138, p.106097-106097, Article 106097

2020

Volltextzugriff (PDF)

Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32–13 T > G variant

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.106-116

2019

Volltextzugriff (PDF)

Human Myo19 Is a Novel Myosin that Associates with Mitochondria

Current biology, 2009-12, Vol.19 (23), p.2008-2013

2009

Volltextzugriff (PDF)

Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource

Molecular genetics and metabolism, 2023-03, Vol.138 (3), p.107525-107525, Article 107525

2023

Volltextzugriff (PDF)

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

The Lancet (British edition), 2011-01, Vol.377 (9763), p.383-392

2011

Volltextzugriff (PDF)

Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutation

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.96-100

2017

Volltextzugriff (PDF)

Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease

Neuromuscular disorders : NMD, 2015-04, Vol.25 (4), p.321-332

2015

Volltextzugriff (PDF)

Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature

Molecular genetics and metabolism, 2021-11, Vol.134 (3), p.223-234

2021

Volltextzugriff (PDF)

Characterization of gait in late onset Pompe disease

Molecular genetics and metabolism, 2015-11, Vol.116 (3), p.152-156

2015

Volltextzugriff (PDF)

Clinical characterization of 20 infants diagnosed with late-onset Pompe disease after positive newborn screening

Molecular genetics and metabolism, 2021-04, Vol.132, p.S28-S29

2021

Volltextzugriff (PDF)

eP041 - Clinical characterization of 20 infants diagnosed with late-onset Pompe disease after positive newborn screening

Molecular genetics and metabolism, 2021-04, Vol.132, p.S28-S29

2021

Volltextzugriff (PDF)

Optimizing Pulmonary Artery Pressures with use of Ivabradine in Cardiomyopathy

Journal of cardiac failure, 2018-08, Vol.24 (8), p.S88-S88

2018

Volltextzugriff (PDF)

Whole-body MRI in late-onset Pompe disease: Clinical utility and correlation with functional measures

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S88-S88

2020

Volltextzugriff (PDF)

Views and experiences of involuntary civil commitment of people who use drugs in Massachusetts (Section 35)

Drug and alcohol dependence, 2024-10, Vol.263, p.112391, Article 112391

2024

Volltextzugriff (PDF)

Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13T>G variant

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.S26-S26

2019

Volltextzugriff (PDF)

Extended treatment with VAL-1221, a novel protein targeting cytoplasmic glycogen, in patients with late-onset Pompe disease

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S24-S24

2020

Volltextzugriff (PDF)

A RETROSPECTIVE LONGITUDINAL STUDY AND COMPREHENSIVE REVIEW OF ADULT PATIENTS WITH GLYCOGEN STORAGE DISEASE TYPE III

Molecular genetics and metabolism, 2022-04, Vol.135 (4), p.275-276

2022

Volltextzugriff (PDF)

Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S88-S88

2020

Volltextzugriff (PDF)

Characterization of gait in late onset Pompe disease

Molecular genetics and metabolism, 2015-02, Vol.114 (2), p.S78-S78

2015

Volltextzugriff (PDF)

Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T > G “late-onset” GAA variant

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S21-S21

2018

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data

Cigarette smoke decreases MARCO expression in macrophages: Implication in Mycoplasma pneumoniae infection

The emerging phenotype of late-onset Pompe disease: A systematic literature review

Risk of respiratory, gastrointestinal, and constitutional health symptoms: A cross-sectional study of Texas adolescent and young adult nicotine and marijuana vapers

Longitudinal trajectories of E-cigarette use among adolescents: A 5-year, multiple cohort study of vaping with and without marijuana

Predictors of JUUL, other electronic nicotine delivery systems, and combustible tobacco initiation among Texas youth

Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32–13 T > G variant

Human Myo19 Is a Novel Myosin that Associates with Mitochondria

Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutation

Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease

Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature

Characterization of gait in late onset Pompe disease

Clinical characterization of 20 infants diagnosed with late-onset Pompe disease after positive newborn screening

eP041 - Clinical characterization of 20 infants diagnosed with late-onset Pompe disease after positive newborn screening

Optimizing Pulmonary Artery Pressures with use of Ivabradine in Cardiomyopathy

Whole-body MRI in late-onset Pompe disease: Clinical utility and correlation with functional measures

Views and experiences of involuntary civil commitment of people who use drugs in Massachusetts (Section 35)

Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13T>G variant

Extended treatment with VAL-1221, a novel protein targeting cytoplasmic glycogen, in patients with late-onset Pompe disease

A RETROSPECTIVE LONGITUDINAL STUDY AND COMPREHENSIVE REVIEW OF ADULT PATIENTS WITH GLYCOGEN STORAGE DISEASE TYPE III

Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease

Characterization of gait in late onset Pompe disease

Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T > G “late-onset” GAA variant

Aktive Filter

Suchergebnisse filtern